LEADER 03548oam 2200469 450 001 9910137089603321 005 20230807212025.0 035 $a(CKB)3710000000824747 035 $a(oapen)https://directory.doabooks.org/handle/20.500.12854/43460 035 $a(EXLCZ)993710000000824747 100 $a20160822h20152015 fy 0 101 0 $aeng 135 $aurmn#---||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aCognition across the psychiatric disorder spectrum $efrom mental health to clinical diagnosis /$fedited by Caroline Gurvich and Susan L. Rossell 210 $cFrontiers Media SA$d2015 210 1$aLausanne, Switzerland :$cFrontiers Media SA,$d2015. 210 4$dİ2015 215 $a1 online resource (93 pages) ;$cillustrations, charts; digital, PDF file(s) 225 0 $aFrontiers research topics 300 $aPublished in Frontiers in Psychiatry. 311 $a2-88919-653-4 320 $aIncludes bibliographical references. 330 $aPsychiatric symptoms are considered to be distributed along a continuum, from mental health to a diagnosable psychiatric disorder. In the case of psychosis, subclinical psychotic experiences (which can include odd behaviours, strange speech, unusual perceptual experiences and social anhedonia) are often referred to as schizotypy. Research examining schizotypal traits in non-clinical populations is rapidly expanding. The exploration of schizotypy may help elucidate factors related to the predisposition to psychiatric disorders (schizophrenia and related disorders). Schizotypy is also a valuable model for exploring cognition as performance is not confounded by issues often present in schizophrenia samples, such as long-term antipsychotic medication usage, social isolation, and recurrent hospitalizations (Jahshan and Sergi, 2007). This is particularly important as cognitive symptoms in schizophrenia are strongly related to quality of life and functional outcomes, yet generally respond poorly to current treatment options. In this Research Topic, we welcome contributions that examine the relationship between cognition and the schizophrenia spectrum. Contributions can be either reviews of recent, relevant literature or experimental studies exploring the contribution of environmental, genetic and other biological factors associated with cognition and schizotypy. While some people with high levels of schizotypy exhibit adaptive strengths (such as creativity) and high levels of subjective well being (Goulding, 2004); other people with high levels of schizotypy who also possess other aetiological risk factors are considered to be at high risk for developing schizophrenia. Further insights into underlying protective factors (such as genetic, epigenetic, environmental, or other personality factors) are also welcomed in this edition. It is particularly important to determine factors that may protect some people with high levels of schizotypy from developing a psychotic disorder. 606 $aPsychiatry 610 $aSchizophrenia 610 $aCognition 610 $aschizotypy 610 $aPsychopathology 610 $aSchizophrenia spectrum 610 $apsychosis 615 0$aPsychiatry. 700 $aSusan L. Rossell$4auth$01376135 702 $aGurvich$b Caroline 702 $aRossell$b Susan L. 801 2$bUkMaJRU 906 $aBOOK 912 $a9910137089603321 996 $aCognition across the psychiatric disorder spectrum$93411468 997 $aUNINA